|
|
Article: Immunome Inc. Presenting Human Monoclonal Antibody Platform at Pharmaceutical Consulting Consortium, INC. (PCCI).
- Article from:
- Blood Weekly
- Article date:
- November 19, 2009
CopyrightCOPYRIGHT 2009 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Immunome, Inc., President and CEO, Tim Pelura, Ph.D., will be presenting information about the company on Monday, November 9, 2009 at the Pharmaceutical Consulting Consortium, Inc. (PCCI) Meeting. The presentation will be also be available for viewing via webcast at www.rxpcci.com (see also Infectious Diseases).
Immunome is a start-up biopharmaceutical company located in the biotechnology incubator at the Lankenau Institute for Medical Research in Wynnewood, PA. Immunome has a proprietary technology for cloning "native" human antibodies (N-huMAbs), high-affinity IgG antibodies that maintain the exact, protective configurations created by the healthy human immune ...